| Decision | Consent granted Section 13(1)(c) Overseas Investment Act 2005 |
|---|---|
| Decision Maker | Toitū Te Whenua LINZ |
| Decision Date | 2 December 2022 |
| Pathway(s) | Significant business assets only |
| Investment | Acquisition of 100% of the shares in Chemiplas Agencies Limited (including the acquisition of its subsidiaries Chemiplas (N.Z.) Limited and Chemiplas Australia Pty Ltd) |
| Consideration | $235,002,111 |
| Applicant | Azelis New Zealand Limited Canada (19.78%) United States of America (10.02%) United Kingdom (4.20%) Netherlands (3.01%) Sweden (2.91%) Singapore (2.50%) Finland (2.15%) Luxembourg (1.96%) China, People's Republic of (1.88%) Denmark (1.83%) South Korea (1.64%) United Arab Emirates (1.44%) Cayman Islands (1.43%) Taiwan (1.33%) Germany (0.74%) Malaysia (0.58%) Colombia (0.45%) Kuwait (0.44%) Japan (0.31%) France (0.29%) Switzerland (0.27%) Various regions (40.84%) |
| Vendor | William Bruce Jacobson on behalf of the shareholders of Chemiplas Agencies Limited New Zealand (100%) |
| Background | The Applicant, Azelis New Zealand Limited, has been granted consent to acquire 100% of the shares in Chemiplas Agencies Limited including its subsidiary Chemiplas (N.Z.) Limited (Chemiplas). Chemiplas is a distributor of specialty chemicals established in New Zealand in 1976. The Applicant is a New Zealand company ultimately owned by Azelis Group NV. Azelis Group NV is listed on the Euronext Brussels stock exchange and its shares are widely held by various investors. The Azelis group is a global service provider in the specialty chemical and food ingredients industry in 57 countries. The Applicant already operates in New Zealand with blending and packing facilities in both Auckland and Christchurch. This transaction requires consent under s 13(1)(c) of the Act. The Applicant has met the investor test. |
| More information | Chris Bargery Anderson Lloyd (Auckland) PO Box 399 Shortland Street Auckland 1140 |
- Last updated